Hospital transplant departments have strict cutoffs for patients with higher body mass indexes because of the increased risk of complications, but GLP-1s such as Ozempic and Wegovy are helping more patients be eligible for surgery.
Read the full post on Becker's Hospital Review | Healthcare News & Analysis
